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SUMMARY
Hepatitis E virus (HEV) is an important pathogen. The animal strain of HEV, swine HEV, is
related to human HEV. The genotype 3 swine HEV infected humans and genotype 3 human HEV
infected pigs. The genotype 4 swine and human HEV strains are genetically related, but it is
unknown whether genotype 4 human HEV can infect pigs. A swine bioassay was utilized in this
study to determine whether genotype 4 human HEV can infect pigs. Fifteen, 4-week-old, specific-
pathogen-free pigs were divided into 3 groups of 5 each. Group 1 pigs were each inoculated
intravenously with PBS buffer as negative controls, group 2 pigs similarly with genotype 3 human
HEV (strain US-2), and group 3 pigs similarly with genotype 4 human HEV (strain TW6196E).
Serum and fecal samples were collected at 0, 7, 14, 21, 28, 35, 42, 49, and 56 days postinoculation
(dpi) and tested for evidence of HEV infection. All pigs were necropsied at 56 dpi. As expected,
the negative control pigs remained negative. The positive control pigs inoculated with genotype 3
human HEV all became infected as evidenced by detection of HEV antibodies, viremia and fecal
virus shedding. All five pigs in group 3 inoculated with genotype 4 human HEV also became
infected: fecal virus shedding and viremia were detected variably from 7 to 56 dpi, and
seroconversion occurred by 28 dpi. The data indicated that genotype 4 human HEV has an
expanded host range, and the results have important implications for understanding the natural
history and zoonosis of HEV.
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INTRODUCTION
Hepatitis E, caused by hepatitis E virus (HEV), occurs predominately in Asia, Africa, and
other developing countries (Emerson and Purcell, 2003; Meng, 2003), but has also been
reported in industrialized countries as sporadic cases (Hsieh et al., 1999; Van der Poel et al.,
2001; Takahashi et al., 2003; Yazaki et al., 2003; Clemente-Casares et al., 2003; Mizuo et
al., 2005; Haagsman et al., 2007; Lewis et al., 2008; Mansuy et al., 2008). The mortality rate
associated with HEV infection is generally low (< 1%), but it can reach as high as 25–30%
in infected pregnant women (Hussaini et al., 1997). Transmission is primarily via the fecal-
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oral route (Emerson and Purcell, 2003), and in countries with less than optimal sanitation
conditions, contaminated water has been the source of major epidemics. However,
increasing evidence suggests that zoonotic transmission may be responsible for the spread of
hepatitis E as well, especially for the sporadic cases (Tei et al., 2003).
HEV is a single-stranded, positive-sense RNA molecule (Purcell, 1996). The approximately
7.2 kb viral genome consists of three open reading frames (ORFs 1, 2, and 3) and short 5’
and 3’ untranslated regions (UTR) (Purcell, 1996; Wang et al., 2000; Huang et al., 2007).
Currently, HEV isolates can be classified into one of four major genotypes (Emerson and
Purcell, 2003; Meng, 2003). Many of the epidemic HEV infections occurring in Asia and
Africa are caused by genotype 1 strains whereas an epidemic occurring in Mexico in 1987
was caused by a genotype 2 strain. Genotype 3 and 4 strains are responsible for sporadic
cases of HEV infections worldwide (Tam et al., 1991; Huang et al., 1992; Schlauder et al.,
1998; Takahashi et al., 2003, 2004; Lewis et al., 2008). The recently identified avian
hepatitis E virus (avian HEV) is genetically and antigenically related to mammalian HEV
strains (Haqshenas et al., 2001; Huang et al., 2004; Guo et al., 2006, 2008) but it remains to
be determined whether avian HEV belongs to a new 5th genotype or a separate genus.
A significant proportion of healthy individuals from industrialized countries are found
positive for HEV antibodies (Thomas et al., 1997; Mast et al., 1997; Meng et al., 2002). The
detection of genotypes 3 and 4 strains of HEV in humans that are genetically closely-related,
or identical in some cases, to HEV strains from pigs (Nishizawa et al., 2003; Yazaki et al.,
2003) suggested that hepatitis E is a zoonotic disease and pigs and maybe other animal
species are reservoir(s) for HEV (Meng, 2003). Thus far HEV has been detected in domestic
and wild pigs (Meng et al., 1997), chickens (Haqshenas et al., 2001; Huang et al., 2004), and
deer (Takahashi et al., 2004). Meng et al. (1997) isolated the first animal strain of HEV,
swine HEV, from a pig in the United States. Since then, swine HEV has been isolated from
pigs in many other countries (Van der Poel et al., 2001; Wang et al., 2002; Yazaki et al.,
2003). Swine HEV isolates obtained from countries worldwide belong to either genotype 3
or 4 (Huang et al., 2002; Cooper et al., 2005).
Genotype 3 swine HEV, which is related both antigenically and genetically to human HEV,
has been shown to infect nonhuman primates. Similarly, the US-2 strain of human HEV has
been shown to infect pigs (Meng et al., 1998b; Halbur et al., 2001). Compared to genotype 3
HEV, genotype 4 strains of human and swine HEVs have not been well characterized
experimentally. The objective of this study was to determine if a genotype 4 strain of human
HEV has the ability to cross species barriers and infect pigs.
MATERIALS AND METHODS
Virus Stocks
The infectious titers of the genotype 3 human HEV stock (US-2 strain) and the genotype 4
human HEV stock (TW6196E strain) used in this study have been determined previously
(Purcell, R. H., unpublished data): 105.3 50% monkey infectious dose (MID50) per ml for the
US-2 strain (Meng et al., 1998b), and 2 × 103 MID50 per ml for the TW6196E strain (Huang
et al., 2002; Cooper et al., 2005).
Pigs
Fifteen, two-week-old, specific-pathogen-free (SPF) pigs were purchased from a
commercial source (Geneticporc Inc, Nebraska). Prior to inoculation, all pigs were
confirmed to be negative for IgG anti-HEV antibodies by an enzyme-linked immunosorbent
assay (ELISA) (Meng et al., 1998a, b; Halbur et al., 2001).
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Experimental design for the swine bioassay
The infectious virus stocks were appropriately diluted to adjust the titer to the same for both
the genotypes 3 and 4 virus stocks. The pigs were randomly divided into 3 groups of 5 pigs
each. Group 1 pigs were each inoculated intravenously (I.V.) with 1 ml of sterile phosphate
buffered saline (PBS) as negative controls, group 2 pigs were each inoculated I.V. with 1 ml
(103 MID50) of the genotype 3 human HEV (strain US-2) as positive controls, and group 3
pigs were each inoculated I.V. with 1 ml (103 MID50) of the genotype 4 human HEV (strain
TW6196E) as the experimental group. The pigs were monitored for evidence of HEV
infections for a total of 8 weeks, and all animals were necropsied at 56 dpi.
Sample collection and processing
Serum samples and fecal swabs were collected weekly from each pig at 0, 7, 14, 21, 28, 35,
42, 49, and 56 days postinoculation (dpi). Serum samples were tested for HEV viremia by a
universal reverse transcription-polymerase chain reaction (RT-PCR) (Huang et al., 2002;
Cooper et al., 2005) and for anti-HEV IgG by ELISA as described previously (Meng et al.,
1997, 1998a, b; Halbur et al., 2001). Fecal swabs (10% suspension in PBS buffer) were also
tested for HEV RNA by RT-PCR.
In addition, samples of feces were collected from each pig in group 2 and group 3 every
three days for the first 4 weeks to investigate the level of HEV viral RNA shedding in the
feces during the acute stage of infection. A portion of the fecal material was made into 10%
fecal suspension in sterile PBS buffer and used for the quantification of HEV RNA by a
real-time RT-PCR. Samples of feces were also tested for HEV RNA by the universal RT-
PCR as described previously (Huang et al., 2002; Cooper et al., 2005) for comparison
purpose.
During necropsy, samples of serum, feces, bile, and liver tissue were collected and stored at
−80°C until use. A portion of the liver tissue samples were homogenized in 10% (w/v)
sterile PBS buffer. The liver homogenates were clarified by centrifugation at 3,000 rpm for
15 minutes at 4°C (Eppendorf centrifuge 5810) and then used for the detection of HEV RNA
by RT-PCR.
ELISA to detect anti-HEV antibodies
A purified, 55 kDa truncated form of the HEV capsid protein, expressed from a recombinant
baculovirus containing the ORF2 of the genotype 1 Sar-55 human strain of HEV, was used
as the antigen for the ELISA as described previously (Meng et al., 1997; 1998a, b).
RT-PCR to detect HEV RNA
To detect HEV RNA in serum samples, fecal swabs, feces, bile, and liver tissue
homogenates of inoculated pigs, a universal RT-PCR assay was performed as described
previously (Huang et al., 2002). The universal RT-PCR assay is capable of detecting all 4
known genotypes of HEV (Huang et al., 2002; Cooper et al., 2005). Briefly, total RNAs
were extracted by the use of Trizol Reagent (GIBCO-BRL) from 100 µl of the serum, fecal
suspension, bile, or 10% liver homogenate. The total RNA was resuspended in 11.0 µl of
DNase, RNase-, and proteinase-free water (Invitrogen). Reverse transcription was
performed at 42°C for 60 minutes with 1 µl (10 µM) of the reverse primer 3157N [5’-
CCCTTA(G)TCC(T)TGCTGA(C)GCATTCTC-3’], 1 µl (200 U/µl) of Superscript II
reverse transcriptase (Invitrogen), 1 µl of 0.1 M dithiothreitol, 4 µl of 5 × RT buffer, 0.5 µl
(40 U/µl) of RNase inhibitor (Promega), and 1 µl of 10mM deoxynucleoside triphosphates.
Ten microliters of the resulting cDNA was subsequently amplified in a 50 µl PCR reaction
with AmpliTaq Gold DNA polymerase (Applied Biosystems).
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The nested universal RT-PCR assay amplifies a region within the ORF2 capsid gene (Huang
et al., 2002; Cooper et al., 2005). The first round PCR was performed with a set of
degenerate HEV primers: 3156N [forward, 5’-
AATTATGCC(T)CAGTAC(T)CGG(A)GTTG- 3’] and 3157N [reverse, 5’-
CCCTTA(G)TCC(T)TGCTGA(C)GCATTCTC-3’]. The second round PCR was performed
with another set of degenerate HEV primers using the first round PCR product as the
template: 3158N [forward, 5’- GTT(A)ATGCTT(C)TGCATA(T)CATGGCT-3’] and 3159N
[reverse, 5’- AGCCGACGAAATCAATTCTGTC-3’]. The PCR parameters for the first and
second round PCR were similar with an initial denaturation step at 95°C for 9 minutes,
followed by 39 cycles of denaturation for 1 minute at 94°C, annealing for 1 minute at 42°C,
extension for 1 minute at 72°C, and a final extension at 72°C for 7 minutes. The expected
final product of the universal nested RT-PCR was 348 bp.
Real-time RT-PCR to quantify HEV RNA in feces
Quantification of HEV RNA in the feces (10% feces suspension in PBS buffer) during the
first 4 weeks of infection was performed essentially as described previously (Jothikumar et
al., 2005) with a few modifications. Briefly, to generate a HEV RNA standard, a plasmid
containing a region of ORF3 was constructed from the infectious cDNA clone pSHEV-3 of
a genotype 3 swine HEV (Huang et al., 2005, 2007) using the TA Cloning Kit (Invitrogen)
pCR®2.1 vector and the following primers: [forward, 5’ – ATGCTGCCCGCGCCACCG –
3’] and [reverse, 5’ – AGGGGTTGGTTGGATGAA – 3’]. Plasmid DNA was purified using
the GenElute™ Plasmid Miniprep Kit (Sigma-Aldrich) and quantified using the Nanodrop
ND-1000 according to the manufacturer’s instructions. The mMESSAGE mMACHINE®
High Yield Capped RNA Transcription Kit (Ambion) was used to generate an in vitro RNA
transcript from the plasmid DNA template containing a T7 promoter according to the
manufacturer’s protocols. Plasmid DNA was removed completely with DNase I treatment
and the integrity of the RNA transcript was checked by gel electrophoresis.
A standard curve was generated from 10-fold serial dilutions of the in vitro-synthesized
HEV RNA standard and used for real-time RT-PCR with the QuantiTect Probe RT-PCR Kit
(Qiagen) on an iCycler (Bio-Rad). The primers used for the real-time PCR are: forward [5’ –
GGTGGTTTCTGGGGTGAC – 3’] and reverse [5’ – GGTTGGTTGGATGAATATAGGG
– 3’]. The probe [5’ – TGATTCTCAGCCCTTCGC – 3’] contained a 5’ 6-carboxy
fluorescein fluorophore (FAM) and a 3’ black hole quencher (BHQ-1). The primers
(Invitrogen) and the probe (MWG Biotech) were commercially synthesized. HEV RNA was
extracted from 10% fecal suspensions of group 2 and group 3 pigs collected at different time
points during the first 4 weeks post-inoculation. In brief, 100 µl of fecal suspension was
mixed with 1 ml of Trizol Reagent and 200 µl of chloroform. The aqueous phase was added
to the RNeasy Mini Kit spin column (Qiagen) for RNA extraction and purification using on-
column DNase digestion according to the manufacturer’s instructions and the RNA was
stored at −80°C until use. Reverse transcription was carried out at 50°C for 30 minutes,
followed by denaturation at 95°C for 15 minutes. Real-time PCR amplification was
performed with 50 cycles at 95°C for 10 seconds, 55°C for 20 seconds and 72°C for 15
seconds. The reproducibility of the assay was determined by testing each sample in triplicate
and the mean value was calculated.
RESULTS
As expected, all pigs in the negative control group 1 inoculated with sterile PBS buffer
remained seronegative throughout the study, and there was no detectable HEV viremia, fecal
virus shedding, or seroconversion in group 1 pigs (Fig. 1, Table 1). All pigs in the positive
control group 2 inoculated with genotype 3 human HEV (strain US-2) became infected, as
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evidenced by seroconversion to IgG anti-HEV as early as 2 weeks postinoculation (wpi),
viremia, and fecal virus shedding (Fig. 1, Table 1).
All five pigs in the experimental group 3 inoculated with the genotype 4 human HEV strain
TW6196E also became infected. Seroconversion started at 2 wpi, and by 4 wpi all pigs had
seroconverted to IgG anti-HEV and remained seropositive at the end of the 8-week study
(Fig. 1). Viremia and fecal virus shedding were also detected variably in group 3 pigs
(Table1). Viremia is transient and in very short duration in both genotypes 3 and 4 human
HEV-infected pigs (Table 1). Fecal virus shedding in the group 2 pigs inoculated with the
genotype 3 human HEV lasted approximately 4 weeks: by weeks 5 and 6, there is only one
pig that still shed virus in feces. In group 3 pigs inoculated with the genotype 4 human HEV,
fecal virus shedding appears to last longer: 4/5 pigs at 6 wpi and 3/5 pigs at 8 wpi still shed
virus in feces (Table 1).
In general, fecal virus shedding in pigs infected by swine HEV or genotype 3 human HEV
occur in the first 4 to 5 wpi (Halbur et al., 2001; Meng et al., 1998). Therefore, to evaluate
the onset and pattern of fecal virus shedding between genotype 3 and genotype 4 human
HEV-infected pigs, the amounts of fecal viral shedding during the first 4 weeks of the
infection were determined by a real-time PCR. HEV RNA was detected in fecal samples
from group 2 and group 3 pigs as early as 3 days postinoculation (dpi). In group 2 pigs
infected with genotype 3 human HEV, viral RNA levels in feces ranged from 4.49 to 10.10
log copies per mg of feces during the first 4 weeks. For group 2 pigs, the virus titers peaked
in the feces of most pigs at approximately 12 to 18 dpi (Table 2, Fig. 2). Fecal virus
shedding disappeared in one pig (ID 32) at 24 dpi, whereas another pig (ID 44) stopped
shedding virus at 27 dpi. The remaining 3 pigs in group 2 still shed virus in feces at the end
of the 4 week observation period (Table 2). In group 3 pigs infected by the genotype 4
human HEV, viral RNA levels in feces ranged from 5.21 to 10.26 log copies per mg of feces
(Table 2). The fecal virus titers of most group 3 pigs peaked at approximately 9 to 21 dpi
(Table 2, Fig. 2). Samples with detectable HEV RNA in feces by real-time RT-PCR (Table
2) were also determined to be positive by the universal RT-PCR (data not shown)).
All pigs from each group were necropsied at 8 wpi. The PCR products amplified from
serum, fecal swabs, bile, and liver samples from two selected pigs from group 2 and group 3
were sequenced for the ORF2 gene region. Sequence analyses confirmed that the viruses
recovered from the experimentally infected pigs originated from the respective inoculum
(data not shown).
DISCUSSION
The rare incidence of human-to-human HEV transmission in endemic regions suggests that
animal reservoirs of HEV may exist (Meng, 2003). Human HEV strains (US-1 and US-2)
recovered from hepatitis E patients in the United States are closely related to the genotype 3
swine HEV strain isolated from a pig in the same geographical area (Meng et al., 1998b;
Schlauder et al., 1998). Similarly, genotype 4 human HEV isolates obtained from hepatitis E
patients in China and Taiwan (Hsieh et al., 1999; Wang et al., 2002; Wu et al., 2002) are
very similar to swine HEV isolates obtained from pigs in the same area. These findings
strongly suggest that pigs are reservoirs for genotype 3 and genotype 4 strains of HEV.
Meng et al. (1998b) has demonstrated, experimentally, that the genotype 3 swine HEV was
able to cross species barriers and infect rhesus monkeys and a chimpanzee and, in a
reciprocal experiment, that SPF pigs were experimentally infected with the US-2 strain of
genotype 3 human HEV. However, a genotype 1 human HEV strain (Sar-55) and the
genotype 2 human HEV strain (Mex-14) were not able to infect SPF pigs under
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experimental conditions (Meng et al., 1998a). The failure to infect pigs with the Sar-55
(genotype 1) and Mex-14 (genotype 2) HEV strains suggest that the transmissibility of
human HEV to other species such as pigs varies from HEV genotype to genotype.
Therefore, it is important to determine whether or not the genotype 4 human HEV strain
identified recently has the ability to infect across species barriers.
The genomes of genotype 4 human HEV strains have been shown to be closely related to
genotype 4 swine HEV strains obtained from the same geographic region (Nishizawa et al.,
2003; Takahashi et al., 2003). A genotype 4 swine HEV strain isolated from a pig on a
swine farm in Hokkaido, Japan was found to have 99% nucleotide sequence identity with a
genotype 4 human HEV isolate obtained from a patient with sporadic acute hepatitis E in
Hokkaido (Nishizawa et al., 2003). Similar results have also been reported with genotype 4
swine and genotype 4 human HEV strains in Bali, Indonesia (Wibawa et al., 2007). In
addition, Yazaki et al. (2003) found that a genotype 4 swine HEV isolate obtained from pig
livers purchased in local grocery stores in Hokkaido, Japan shared 97.8–100% nucleotide
sequence identity with genotype 4 human HEV strains obtained from patients with sporadic
acute or fulmninant hepatitis E who had consumed undercooked pig livers prior to the onset
of the disease. The seroprevalence of IgG anti-HEV, when tested with a genotype 4 HEV
capsid protein as the antigen, was found to be 58% in pigs from commercial herds in
Hokkaido (Takahashi et al., 2003). These data strongly suggest that, similar to genotype 3
HEV, genotype 4 HEV may also have an expanded host range. In fact, recently Arankalle et
al. (2006) were able to infect rhesus monkeys with a genotype 4 Indian strain of swine HEV.
In this present study, we demonstrated that SPF pigs experimentally inoculated with
genotype 4 human HEV (strain TW6196E) became infected. Fecal virus shedding and
viremia were detected variably from 7 to 56 dpi, seroconversion occurred by 28 dpi. There
are a few minor discrepancies in HEV RNA positivity detected in the weekly fecal swabs by
RT-PCR (Table 1) and in the feces samples collected every three days during the first 4
weeks (Table 2). For example, the fecal swabs from weeks 1 and 2 in pig number 28 were
tested negative for HEV RNA (Table 1), whereas the same pig was tested positive for HEV
RNA during the first two weeks when the feces samples (instead of swabs) were tested
(Table 2). This is not surprising since the amounts of fecal materials collected weekly by
fecal swabs are variable (Meng et al., 1999a) and sometimes only a small amount of fecal
materials can be obtained by swabs in some pigs, and thus likely reflecting the minor
discrepancies of the results between fecal swabs (Table 1) and feces (Table 2). The fecal
virus shedding in pigs infected with genotype 4 human HEV appears to last longer than pigs
infected with the genotype 3 human HEV. With the exception of one pig, the fecal virus
shedding in all other 4 genotype 3 HEV-infected pigs disappeared after 4 wpi (Table 1). In
contrast, three of the 5 genotype 4 HEV-infected pigs still shed virus at the end of the 8
week study. However, the titers of viral RNA levels quantified by real-time PCR were
comparable in pigs infected with genotype 3 human HEV and genotype 4 human HEV, and
there is no significant difference in virus RNA titers in feces (Fig. 2). It remains to be
determined whether there exist virulence differences between genotype 3 and genotype 4
human HEV strains. Since both genotypes 3 and 4 human HEV strains are now shown to
infect pigs, future experiments to compare the pathogenicity of these strains in pigs can now
be performed.
This is the first report of a genotype 4 human HEV strain crossing species barriers and
infecting pigs, thereby supporting field observations that genotypes 1 and 2 HEV strains are
restricted to humans, whereas genotypes 3 and 4 HEV strains have a broader host range that
include both humans and swine. The results from this study have important implications for
understanding the natural history and zoonosis of HEV. The ubiquitous nature of genotype 3
and 4 swine HEV worldwide (Banks et al., 2004; Cooper et al., 2005; Wang et al., 2002,
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Yazaki et al., 2003;) and the demonstrated ability to infect across species raises potential
public health concerns. Approximately 60–80% of swine herds in the United States are
infected with swine HEV and swine veterinarians in the United States have an increased risk
for zoonotic infection (Meng et al., 2002). Similar results have also been reported amongst
pig handlers in Moldova (Drobeniuc et al., 2001) and Taiwan (Hsieh et al., 1999). Sporadic
cases of hepatitis E have been linked to the consumption of raw or undercooked pig livers
(Yazaki et al., 2003). Therefore, individuals who consume raw or undercooked pig livers are
also at an increased risk for zoonotic HEV infection (Yazaki et al., 2003; Feagins et al.,
2007). On the other hand, since both genotypes 3 and 4 human HEV can infect pigs, thus
pigs may play an important role in the survival and transmission of genotypes 3 and 4
human HEV in human populations in endemic areas. Future studies are warranted to
determine the mechanism of cross-species infection by genotypes 3 and 4 HEV strains.
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FIG. 1.
Seroconversion to IgG anti-HEV in HEV-inoculated and control pigs. Panel A, pigs
inoculated with sterile phosphate buffered saline (PBS) as negative controls (group 1);
Panel B, pigs inoculated with a genotype 3 human HEV (strain US-2) as positive controls
(group 2); Panel C, pigs inoculated with a genotype 4 human HEV (strain TW6196E) as the
experimental group (group 3). The ELISA cutoff OD value is 0.30.
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FIG. 2.
Average titers of HEV RNA in feces (expressed as log copies per mg of feces) from all five
pigs in each group at the indicated days post-inoculation (dpi) during the first 4 weeks of
infection. The open bars represent pigs inoculated with the genotype 3 human HEV (Strain
US-2) and the filled bars represent pigs inoculated with genotype 4 human HEV (Strain
TW6196E). The error bars represent ± standard deviation.
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